Search
news › a-potentially-more-effective-treatment-for-her2-mutant-metastatic-breast-cancer
… the drug neratinib, but the responses are variable and often not durable. Looking to better understand the underlying … variation, a team led by researchers at Baylor College of Medicine investigated whether different HER2 mutations drove … and lobular breast cancer, which is understudied when compared to ductal breast cancer,” said leading author Dr. …
news › dr-david-nelson-receives-ashg-leadership-award
… The American Society of Human Genetics (ASHG) has named Dr. David L. Nelson , professor of molecular and human … includes a $10,000 prize, is named in honor of the late Dr. Victor A. McKusick and is bestowed upon an individual … receive ASHG’s leadership award named for Victor McKusick. Dr. McKusick was a giant in our field of human genetics; he …
research › ... › news
… dynamics in RNA function. To celebrate, we had a Mexican feast at a lab favorite - Cuchara. Welcome to Rebekah, … by their work. In addition to mastering his project, Khoa has become an expert in Houston Banh Mi’s, which we … Physical & Structural Biology Program) and Maddie (Cancer & Cell Biology Program) …
research › ... › lab-members
… Dr. Shen has over 20 years of experience in cancer epigenetics. … which have been collectively cited more than 9,700 times. Since starting her laboratory at Baylor College of Medicine in 2009, her research team has been conducting … how epimutation facilitates lung cancer progression and metastasis. She is also involved in developing novel …
departments › ... › long-covid-syndrome-forum
… Dec. 10, 2022 from 8 a.m. – Noon Forum sessions will feature faculty … LCSF 2022 Curriculum Handout … Long COVID Syndrome Forum Agenda - Dec. 10, 2022 …
news › study-cholesterol-substantially-reduced-with-oral-pcsk9-inhibitor
… Congress of Cardiology found that an oral PCSK9 inhibitor called MK-0616 reduced LDL, or “bad,” cholesterol by more … subtilisin/kexin type 9 (PCSK9) inhibitor, substantially reduced levels of low-density lipoprotein (LDL) … oral PCSK9 inhibitors to be tested in clinical trials. All the currentlyavailable PCSK9 inhibitors must be …
news › grb10-offers-a-potential-new-approach-for-treating-obesity
… For many people, keeping a healthy body weight can be a challenge. According to the Centers for Disease Control and … lead to a reduction of fat tissue and weight loss. When all works well, this leptin-mediated feedback loop between … that would regulate leptin activity and could potentially be used to overcome leptin resistance. The team …
news › new-policies-needed-to-maximize-psychedelics-therapeutic-potential
… Ethics and Health Policy at Baylor. “Therefore, the need has never been greater to anticipate, identify and discuss … mitigation strategies specifying conditions for safe use, which also may help promote effectiveness, and work with … the state-by-state legalization model used for marijuana, which has not provided adequate incentives for the …
research › ... › services
… assisted use. Instrument can only be used if a reservation has been made with Core staff. … or as arrayed libraries in multi-well plates. The core has several lentiviral destination vectors and can provide …
news › long-range-neuronal-connections-drive-glioblastoma-invasion
… Glioblastoma (GBM) is the most aggressive and lethal form of brain tumor. Despite … drive tumor infiltration. “Previous studies have shown associations between the presence of GBM and increased … Emmet Huang-Hobbs in Dr. Benjamin Deneen ’s lab. To study how neurons stimulate GBM infiltration, the researchers …